Kelonia Therapeutics


Kelona is revolutionizing gene delivery to expand the impact of genetic medicines.

Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.

Industries

Employees

11-50

Links


Org chart

Kevin Friedman
Chief Scientific Officer & President
Collapse
Michael McDonald
SVP & Head, IP & Legal Affairs
Travis Quigley
SVP, Clinical Development
Laura Sandler
SVP, Strategic Operations
Stacy Gilroy
VP, Talent & Culture
Shannon Grande Contrastano
Senior Director, Preclinical Sciences
Emily Beura
Associate Director, T Cell Biology
Sarah Tannehill-Gregg
Vice President, Preclinical Development
Vionnie Yu
Executive Director

Board & advisors

Michael Birnbaum
Board Member
Bob More
Board Member
Bryan Roberts
Board Member


Offices